By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioTime, Inc. 

1301 Harbor Bay Parkway

Alameda  California  94502  U.S.A.
Phone: 510-521-3390 Fax: 510-521-3389


Company News
BioTime (BTX) Announces Dual Listing On The Tel Aviv Stock Exchange 9/4/2015 7:51:49 AM
ESI BIO - A Division Of BioTime (BTX) Launches New Research Technology Platform, Vascunet Pericyte Co-Culture Assay 9/2/2015 10:55:24 AM
BioTime (BTX) Subsidiary Asterias Biotherapeutics Concludes Recruitment Of Initial Safety Cohort Of The SCiStar Phase 1/2a Dose-Escalation Clinical Trial Of AST-OPC1 For Complete Cervical Spinal Cord Injury 9/1/2015 11:06:04 AM
BioTime (BTX) Chief Executive Officer Dr. Michael D. West To Be Keynote Speaker At Stem Cells & Regenerative Medicine Congress 2015 9/1/2015 9:04:33 AM
The Wistar Institute And BioTime (BTX) Subsidiary OncoCyte Corporation Expand Agreement To Develop Molecular Diagnostic Test For The Detection Of Lung Cancer 8/18/2015 11:17:30 AM
BioTime (BTX) Reports Second Quarter 2015 Results And Recent Developments 8/11/2015 11:10:31 AM
BioTime (BTX) Announces the Issuance of 27 New Patents Protecting Stem Cell-Based Product Development 8/10/2015 10:48:16 AM
BioTime (BTX) Release: OncoCyte Corporation’s Collaborators At The Wistar Institute Present Positive Clinical Interim Results Of Blood-Based Diagnostic Test For Non-Invasive Detection Of Lung Cancer 5/19/2015 1:15:03 PM
BioTime (BTX)'s Subsidiary Cell Cure Neurosciences Awarded $1.6 Million Grant From Israel’s Office Of The Chief Scientist 5/13/2015 8:19:58 AM
BioTime (BTX) Reports First Quarter 2015 Results And Recent Corporate Accomplishments 5/11/2015 11:54:14 AM